Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 8, 2009, Pages 1610-1619

  Mangoni, Maria Luisa ^a   Shai, Yechiel ^b  

^a Pasteur Institute   (Italy)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Anti endotoxin activity; Frog skin antimicrobial peptide; Mode of action; Peptide membrane interaction; Synergism; Temporin

Indexed keywords

LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTIFICIAL MEMBRANE; CYTOKINE RELEASE; DRUG DESIGN; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FROG; GRAM NEGATIVE BACTERIUM; INNATE IMMUNITY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; STRUCTURE ANALYSIS; TARGET CELL;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BASE SEQUENCE; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIA; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; PROTEINS;

AMPHIBIA; ANIMALIA; ANURA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; RANA TEMPORARIA;

EID: 67649401884     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.04.021     Document Type: Review

References (103)

1. Erspamer V. Bioactive secretions of the amphibian integument. In: Heatwole H. (Ed). Amphibian Biology 1 (1994), Surray Beatty and Sons, Chipping Northon 178-350
2. Bevins C.L., and Zasloff M. Peptides from frog skin. Annu. Rev. Biochem. 59 (1990) 395-414
3. Simmaco M., Mignogna G., and Barra D. Antimicrobial peptides from amphibian skin: what do they tell us?. Biopolymers 47 (1998) 435-450
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
5. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13 (1995) 61-92
6. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 173 (2000) 5-16
7. Mor A., Hani K., and Nicolas P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 269 (1994) 31635-31641
8. Rollins-Smith L.A., Doersam J.K., Longcore J.E., Taylor S.K., Shamblin J.C., Carey C., and Zasloff M.A. Antimicrobial peptide defenses against pathogens associated with global amphibian declines. Dev. Comp. Immunol. 26 (2002) 63-72
9. Mangoni M.L. Temporins, anti-infective peptides with expanding properties. Cell. Mol. Life Sci. 63 (2006) 1060-1069
10. Gibson B.W., Tang D.Z., Mandrell R., Kelly M., and Spindel E.R. Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J. Biol. Chem. 266 (1991) 23103-23111
11. Simmaco M., Barra D., Chiarini F., Noviello L., Melchiorri P., Kreil G., and Richter K. A family of bombinin-related peptides from the skin of Bombina variegata. Eur. J. Biochem. 199 (1991) 217-222
12. Mangoni M.L., Grovale N., Giorgi A., Mignogna G., Simmaco M., and Barra D. Structure-function relationships in bombinins H, antimicrobial peptides from Bombina skin secretions. Peptides 21 (2000) 1673-1679
13. Mignogna G., Simmaco M., Kreil G., and Barra D. Antibacterial and haemolytic peptides containing d-alloisoleucine from the skin of Bombina variegata. EMBO J. 12 (1993) 4829-4832
14. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5449-5453
15. Mor A., and Nicolas P. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem. 219 (1994) 145-154
16. Mor A., Amiche M., and Nicolas P. Structure, synthesis, and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin. Biochemistry 33 (1994) 6642-6650
17. Morikawa N., Hagiwara K., and Nakajima T. Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem. Biophys. Res. Commun. 189 (1992) 184-190
18. Simmaco M., Mignogna G., Barra D., and Bossa F. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J. Biol. Chem. 269 (1994) 11956-11961
19. Goraya J., Wang Y., Li Z., O'Flaherty M., Knoop F.C., Platz J.E., and Conlon J.M. Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens. Eur. J. Biochem. 267 (2000) 894-900
20. Simmaco M., Mignogna G., Canofeni S., Miele R., Mangoni M.L., and Barra D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 242 (1996) 788-792
21. Conlon J.M., Kolodziejek J., and Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta 1696 (2004) 1-14
22. Rosenfeld Y., Barra D., Simmaco M., Shai Y., and Mangoni M.L. A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J. Biol. Chem. 281 (2006) 28565-28574
23. Westerhoff H.V., Zasloff M., Rosner J.L., Hendler R.W., De Waal A., Vaz Gomes A., Jongsma P.M., Riethorst A., and Juretic D. Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur. J. Biochem. 228 (1995) 257-264
24. Simmaco M., De Biase D., Severini C., Aita M., Erspamer G.F., Barra D., and Bossa F. Purification and characterization of bioactive peptides from skin extracts of Rana esculenta. Biochim. Biophys. Acta 1033 (1990) 318-323
25. Conlon J.M. Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae. Peptides 29 (2008) 1815-1819
26. Argiolas A., and Pisano J.J. Isolation and characterization of two new peptides, mastoparan C and crabrolin, from the venom of the European hornet, Vespa crabro. J. Biol. Chem. 259 (1984) 10106-10111
27. Clark D.P., Durell S., Maloy W.L., and Zasloff M. Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J. Biol. Chem. 269 (1994) 10849-10855
28. Amiche M., Seon A.A., Pierre T.N., and Nicolas P. The dermaseptin precursors: a protein family with a common preproregion and a variable C-terminal antimicrobial domain. FEBS Lett. 456 (1999) 352-356
29. Bradbury A.F., and Smyth D.G. Peptide amidation. Trends Biochem. Sci. 16 (1991) 112-115
30. Wade D., Silberring J., Soliymani R., Heikkinen S., Kilpelainen I., Lankinen H., and Kuusela P. Antibacterial activities of temporin A analogs. FEBS Lett. 479 (2000) 6-9
31. Rinaldi A.C., Mangoni M.L., Rufo A., Luzi C., Barra D., Zhao H., Kinnunen P.K., Bozzi A., Di Giulio A., and Simmaco M. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem. J. 368 (2002) 91-100
32. Conlon J.M., Al-Kharrge R., Ahmed E., Raza H., Galadari S., and Condamine E. Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa. Peptides 28 (2007) 2075-2080
33. Abbassi F., Oury B., Blasco T., Sereno D., Bolbach G., Nicolas P., Hani K., Amiche M., and Ladram A. Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica. Peptides 29 (2008) 1526-1533
34. Abbassi F., Galanth C., Amiche M., Saito K., Piesse C., Zargarian L., Hani K., Nicolas P., Lequin O., and Ladram A. Solution structure and model membrane interactions of temporins-SH, antimicrobial peptides from amphibian skin. A NMR spectroscopy and differential scanning calorimetry study. Biochemistry 47 (2008) 10513-10525
35. Mangoni M.L., Saugar J.M., Dellisanti M., Barra D., Simmaco M., and Rivas L. Temporins, small antimicrobial peptides with leishmanicidal activity. J. Biol. Chem. 280 (2005) 984-990
36. Chinchar V.G., Bryan L., Silphadaung U., Noga E., Wade D., and Rollins-Smith L. Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides. Virology 323 (2004) 268-275
37. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 1778 (2008) 357-375
38. Rozek T., Wegener K.L., Bowie J.H., Olver I.N., Carver J.A., Wallace J.C., and Tyler M.J. The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem. 267 (2000) 5330-5341
39. Doyle J., Brinkworth C.S., Wegener K.L., Carver J.A., Llewellyn L.E., Olver I.N., Bowie J.H., Wabnitz P.A., and Tyler M.J. nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. Eur. J. Biochem. 270 (2003) 1141-1153
40. Won H.S., Seo M.D., Jung S.J., Lee S.J., Kang S.J., Son W.S., Kim H.J., Park T.K., Park S.J., and Lee B.J. Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5. J. Med. Chem. 49 (2006) 4886-4895
41. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., and Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3792-3796
42. Hancock R.E., and Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206 (2002) 143-149
43. Trent M.S. Biosynthesis, transport, and modification of lipid A. Biochem. Cell. Biol. 82 (2004) 71-86
44. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., Di Padova F., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8 (1994) 217-225
45. Mangoni M.L., Papo N., Barra D., Simmaco M., Bozzi A., Di Giulio A., and Rinaldi A.C. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 380 (2004) 859-865
46. Carotenuto A., Malfi S., Saviello M.R., Campiglia P., Gomez-Monterrey I., Mangoni M.L., Gaddi L.M., Novellino E., and Grieco P. A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. J. Med. Chem. 51 (2008) 2354-2362
47. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462 (1999) 55-70
48. Henzler Wildman K.A., Lee D.K., and Ramamoorthy A. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42 (2003) 6545-6558
49. Ramamoorthy A., Thennarasu S., Tan A., Lee D.K., Clayberger C., and Krensky A.M. Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta 1758 (2006) 154-163
50. Ramamoorthy A., Thennarasu S., Tan A., Gottipati K., Sreekumar S., Heyl D.L., An F.Y., and Shelburne C.E. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. Biochemistry 45 (2006) 6529-6540
51. Powers J.P., Tan A., Ramamoorthy A., and Hancock R.E. Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry 44 (2005) 15504-15513
52. Rosenfeld Y., Papo N., and Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281 (2006) 1636-1643
53. Sinha S., Shimada T., Ramamurthy T., Bhattacharya S.K., Yamasaki S., Takeda Y., and Nair G.B. Prevalence, serotype distribution, antibiotic susceptibility and genetic profiles of mesophilic Aeromonas species isolated from hospitalized diarrhoeal cases in Kolkata, India. J. Med. Microbiol. 53 (2004) 527-534
54. Deodhar L.P., Saraswathi K., and Varudkar A. Aeromonas spp. and their association with human diarrheal disease. J. Clin. Microbiol. 29 (1991) 853-856
55. Yamamoto T., Ishii T., Sanaka M., Saitoh M., and Kuyama Y. Ileal ulcers due to Aeromonas hydrophilia infection. J. Clin. Gastroenterol. 38 (2004) 911
56. Marr A.K., Gooderham W.J., and Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006) 468-472
57. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348 (2003) 1546-1554
58. Rietschel E.T., Brade H., Holst O., Brade L., Muller-Loennies S., Mamat U., Zahringer U., Beckmann F., Seydel U., Brandenburg K., Ulmer A.J., Mattern T., Heine H., Schletter J., Loppnow H., Schonbeck U., Flad H.D., Hauschildt S., Schade U.F., Di Padova F., Kusumoto S., and Schumann R.R. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216 (1996) 39-81
59. Zhang F.X., Kirschning C.J., Mancinelli R., Xu X.P., Jin Y., Faure E., Mantovani A., Rothe M., Muzio M., and Arditi M. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274 (1999) 7611-7614
60. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4 (2002) 903-914
61. Kubo Y., Fukuishi N., Yoshioka M., Kawasoe Y., Iriguchi S., Imajo N., Yasui Y., Matsui N., and Akagi M. Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflamm. Res. 56 (2007) 70-75
62. Gee K., Kozlowski M., and Kumar A. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells. J. Biol. Chem. 278 (2003) 37275-37287
63. Mukhopadhyay S., Herre J., Brown G.D., and Gordon S. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 112 (2004) 521-530
64. Dinarello C.A. Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216 (1996) 133-165
65. Prins J.M., Kuijper E.J., Mevissen M.L., Speelman P., and van Deventer S.J. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63 (1995) 2236-2242
66. Byl B., Clevenbergh P., Kentos A., Jacobs F., Marchant A., Vincent J.L., and Thys J.P. Ceftazidime- and imipenem-induced endotoxin release during treatment of Gram-negative infections. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 804-807
67. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
68. Angus D.C., and Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 29 (2001) S109-116
69. Scott M.G., Vreugdenhil A.C., Buurman W.A., Hancock R.E., and Gold M.R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164 (2000) 549-553
70. Jerala R., and Porro M. Endotoxin neutralizing peptides. Curr. Top. Med. Chem. 4 (2004) 1173-1184
71. Hancock R.E., and Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8 (2000) 402-410
72. Scott M.G., Yan H., and Hancock R.E. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect. Immun. 67 (1999) 2005-2009
73. Mookherjee N., Rehaume L.M., and Hancock R.E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 11 (2007) 993-1004
74. Soravia E., Martini G., and Zasloff M. Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett. 228 (1988) 337-340
75. Nagaoka I., Hirota S., Yomogida S., Ohwada A., and Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49 (2000) 73-79
76. Lauth X., Babon J.J., Stannard J.A., Singh S., Nizet V., Carlberg J.M., Ostland V.E., Pennington M.W., Norton R.S., and Westerman M.E. Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections. J. Biol. Chem. 280 (2005) 9272-9282
77. Nishida M., Imura Y., Yamamoto M., Kobayashi S., Yano Y., and Matsuzaki K. Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the mechanism of synergism. Biochemistry 46 (2007) 14284-14290
78. Hara T., Mitani Y., Tanaka K., Uematsu N., Takakura A., Tachi T., Kodama H., Kondo M., Mori H., Otaka A., Nobutaka F., and Matsuzaki K. Heterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking study. Biochemistry 40 (2001) 12395-12399
79. Matsuzaki K., Mitani Y., Akada K.Y., Murase O., Yoneyama S., Zasloff M., and Miyajima K. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 37 (1998) 15144-15153
80. Mangoni M.L., Epand R.F., Rosenfeld Y., Peleg A., Barra D., Epand R.M., and Shai Y. Lipopolysaccharide, a key molecule involved in the synergism between temporinsin inhibiting bacterial growth and in endotoxin neutralization. J. Biol. Chem. 283 (2008) 22907-22917
81. Rosenfeld Y., Sahl H.G., and Shai Y. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. Biochemistry 47 (2008) 6468-6478
82. Li P., Wohland T., Ho B., and Ding J.L. Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. J. Biol. Chem. 279 (2004) 50150-50156
83. Hirohashi N., and Morrison D.C. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 64 (1996) 1011-1015
84. Berczi I., Bertok L., and Bereznai T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 12 (1966) 1070-1071
85. Iliev D.B., Roach J.C., Mackenzie S., Planas J.V., and Goetz F.W. Endotoxin recognition: in fish or not in fish?. FEBS Lett. 579 (2005) 6519-6528
86. Lewis D. Antimicrobial resistance surveillance: methods will depend on objectives. J. Antimicrob. Chemother. 49 (2002) 3-5
87. Lu Y., Li J., Yu H., Xu X., Liang J., Tian Y., Ma D., Lin G., Huang G., and Lai R. Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Peptides 27 (2006) 3085-3091
88. Ali M.F., Lips K.R., Knoop F.C., Fritzsch B., Miller C., and Conlon J.M. Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Biochim. Biophys. Acta 1601 (2002) 55-63
89. Conlon J.M., Sonnevend A., Davidson C., Demandt A., and Jouenne T. Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Dev. Comp. Immunol. 29 (2005) 83-90
90. Conlon J.M., Sonnevend A., Patel M., Davidson C., Nielsen P.F., Pal T., and Rollins-Smith L.A. Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J. Pept. Res. 62 (2003) 207-213
91. Halverson T., Basir Y.J., Knoop F.C., and Conlon J.M. Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans. Peptides 21 (2000) 469-476
92. Ali M.F., Knoop F.C., Vaudry H., and Conlon J.M. Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex. Peptides 24 (2003) 955-961
93. Kim J.B., Halverson T., Basir Y.J., Dulka J., Knoop F.C., Abel P.W., and Conlon J.M. Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio. Regul. Pept. 90 (2000) 53-60
94. Zhou J., McClean S., Thompson A., Zhang Y., Shaw C., Rao P., and Bjourson A.J. Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri. Peptides 27 (2006) 3077-3084
95. Conlon J.M., Coquet L., Leprince J., Jouenne T., Vaudry H., Kolodziejek J., Nowotny N., Bevier C.R., and Moler P.E. Peptidomic analysis of skin secretions from Rana heckscheri and Rana okaloosae provides insight into phylogenetic relationships among frogs of the Aquarana species group. Regul. Pept. 138 (2007) 87-93
96. Isaacson T., Soto A., Iwamuro S., Knoop F.C., and Conlon J.M. Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica. Peptides 23 (2002) 419-425
97. Kim J.B., Iwamuro S., Knoop F.C., and Conlon J.M. Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris. J. Pept. Res. 58 (2001) 349-356
98. Basir Y.J., Knoop F.C., Dulka J., and Conlon J.M. Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris. Biochim. Biophys. Acta 1543 (2000) 95-105
99. Conlon J.M., Sonnevend A., Patel M., Al-Dhaheri K., Nielsen P.F., Kolodziejek J., Nowotny N., Iwamuro S., and Pal T. A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Regul. Pept. 118 (2004) 135-141
100. Bevier C.R., Sonnevend A., Kolodziejek J., Nowotny N., Nielsen P.F., and Conlon J.M. Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis). Comp. Biochem. Physiol., C Toxicol. Pharmacol. 139 (2004) 31-38
101. Conlon J.M., Sonnevend A., Patel M., Camasamudram V., Nowotny N., Zilahi E., Iwamuro S., Nielsen P.F., and Pal T. A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties. Biochem. Biophys. Res. Commun. 306 (2003) 496-500
102. Conlon J.M., Abraham B., Sonnevend A., Jouenne T., Cosette P., Leprince J., Vaudry H., and Bevier C.R. Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Regul. Pept. 131 (2005) 38-45
103. Chen T., Zhou M., Rao P., Walker B., and Shaw C. The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides. Peptides 27 (2006) 1738-1744